Fuente y mas informacion:
jueves, 4 de septiembre, 2008
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

Ther Clin Risk Manag. 2008 Feb
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
Hideshima T, Raje N, Richardson PG, Anderson KC


Ther Clin Risk Manag. 2008 Apr
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Managing anemia in lymphoma and multiple myeloma
Birgegard G


N Engl J Med. 2008 Aug 28
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG; VISTA Trial Investigators


Haematologica. 2008 Aug 25
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy
Tricot G, Barlogie B, Zangari M, van Rhee F, Hoering A, Szymonifka J, Cottler-Fox M





____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com

Guia de Uso - http://www.mieloma.com/ayuda/

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Fuente y mas informacion:
jueves,  11 septiembre, 2008
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

Blood Rev. 2008 Sep 5
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
Palumbo A, Dimopoulos M, Miguel JS, Harousseau JL, Attal M, Hussein M, Knop S, Ludwig H, von Lilienfeld-Toal M, Sonneveld P


Leukemia. 2008 Sep 4
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis
Terpos E, Kastritis E, Roussou M, Heath D, Christoulas D, Anagnostopoulos N, Eleftherakis-Papaiakovou E, Tsionos K, Croucher P, Dimopoulos MA


Br J Haematol. 2008 Aug 24
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial
Ponisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Schwarzer A, Ritter U, Rohrberg R, Schwalbe E, Uhlig J, Zehrfeld T, Schirmer V, Haas A, Kreibich U, Niederwieser D; for the East German Study Group of Haematology and Oncology (OSHO)





____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com

Guia de Uso - http://www.mieloma.com/ayuda/

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Fuente y mas informacion:
jueves, 18 septiembre, 2008
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

Leukemia. 2008 Sep 11
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4(+)Foxp3(+) T cells.
Minnema MC, van der Veer MS, Aarts T, Emmelot M, Mutis T, Lokhorst HM


Br J Haematol. 2008 Sep 6
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma
Jagannath S, Barlogie B, Berenson JR, Siegel DS, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Esseltine DL, Anderson KC


Nat Clin Pract Oncol. 2008 Sep 9
http://www.velcade.info/medline/det...49&product=none
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
Dimopoulos MA, Kastritis E





____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com

Guia de Uso - http://www.mieloma.com/ayuda/

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Fuente y mas informacion:
Myeloma Minute - September 19, 2008
http://readtheminute.myeloma.org/

Treatment of Myeloma — Are We Making Progress?
http://content.nejm.org/cgi/content/short/359/9/964
Brian G.M. Durie, M.D.
New England Journal of Medicine; Volume 359:964-966 August 28, 2008 Number 9


Genomic Variation in Myeloma: Design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression free survival
http://www.biomedcentral.com/content/pdf/1741-7015-6-26.pdf
Brian Van Ness*, Christine Ramos, Majda Haznadar, Antje Hoering, Jeffrey Haessler, John Crowley*, Susanna Jacobus, Martin Oken*, Vincent Rajkumar*, Philip Greipp, Bart Barlogie*, Brian Durie*, Michael Katz, Gowtham Atluri, Gang Fang, Rohit Gupta, Michael Steinbach, Vipin Kumar, Richard Mushlin, David Johnson and Gareth Morgan*
BMC Medicine 2008, 6:26
(Provisional PDF of full article)


Germline Polymorphisms as Modulators of Cancer Phenotypes
http://www.biomedcentral.com/content/pdf/1741-7015-6-27.pdf
Patrick Tan
BMC Medicine 2008, 6:27
(Provisional PDF of full article)


Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
http://content.nejm.org/cgi/content/short/359/9/906
Jes?s F. San Miguel, M.D., Ph.D.*, Rudolf Schlag, M.D., Nuriet K. Khuageva, M.D., Ph.D., Meletios A. Dimopoulos, M.D.*, Ofer Shpilberg, M.D., Ph.D., Martin Kropff, M.D., Ivan Spicka, M.D., Ph.D., Maria T. Petrucci, M.D., Antonio Palumbo, M.D.*, Olga S. Samoilova, M.D., Ph.D., Anna Dmoszynska, M.D., Ph.D., Kudrat M. Abdulkadyrov, M.D., Ph.D., Rik Schots, M.D., Ph.D., Bin Jiang, M.D., Maria-Victoria Mateos, M.D., Ph.D., Kenneth C. Anderson, M.D.*, Dixie L. Esseltine, M.D., Kevin Liu, Ph.D., Andrew Cakana, M.D., Helgi van de Velde, M.D., Ph.D., Paul G. Richardson, M.D.*, for the VISTA Trial Investigators
New England Journal of Medicine; Volume 359:906-917 August 28, 2008 Number 9


Genes mirror geography within Europe
http://www.nature.com/nature/journa...ature07331.html
John Novembre, Toby Johnson, Katarzyna Bryc, Zolt?n Kutalik, Adam R. Boyko, Adam Auton, Amit Indap, Karen S. King, Sven Bergmann, Matthew R. Nelson, Matthew Stephens & Carlos D. Bustamante
Nature , | doi :10.1038/nature07331;


Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
P?nisch W, Rozanski M, Goldschmidt H*, Hoffmann FA, Schwarzer A, Rohrberg R, Schwalbe E, Uhlig J, Zehrfeld T, Schirmer V, Haas A, Kreibich U, Niederwieser D, for the East German Study Group of Haematology and Oncology (OSHO).
Br J Haematol. 2008 Aug 24. [Epub ahead of print]


Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
http://bloodjournal.hematologylibra...41614v1?papetoc
Michael Wang, Meletios A. Dimopoulos*, Christine Chen, M. Teresa Cibeira, Michel Attal*, Andrew Spencer, S. Vincent Rajkumar*, Zhinuan Yu, Marta Olesnyckyj, Jerome B Zeldis, Robert D Knight, and Donna M Weber
Blood published 17 September 2008, 10.1182/blood-2008-02-141614





____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com

Guia de Uso - http://www.mieloma.com/ayuda/

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Fuente y mas informacion:
jueves, 25 septiembre, 2008
De: "MMRF SmartBrief "
http://www.multiplemyeloma.org/

Blood. 2008 Sep 19
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
Johnson DC, Corthals S, Ramos C, Hoering A, Cocks K, Dickens NJ, Haessler J, Goldschmidt H, Child JA, Bell SE, Jackson G, Baris D, Rajkumar SV, Davies FE, Durie BG, Crowley J, Sonneveld P, Van Ness B, Morgan GJ.


Biol Blood Marrow Transplant. 2008 Oct;14(10):1134-40
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation
Kumar S, P?rez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Hari P


Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-24
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Comparison of twin and autologous transplants for multiple myeloma
Bashey A, P?rez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P; Plasma Cell Disorders Working Committee


Blood. 2008 Sep 17
http://www.ncbi.nlm.nih.gov/pubmed/...Pubmed_RVDocSum
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Wang M, Dimopoulos MA, Chen C, Cibeira MT, Attal M, Spencer A, Rajkumar SV, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM





____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com

Guia de Uso - http://www.mieloma.com/ayuda/

Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.

Gracias Victor por la informaci?n.
El s?bado lo traducir?....

Saludos fercu y mary

, Victor..
un saludo.